基质金属蛋白酶和金属蛋白酶组织抑制因子在人类腹主动脉瘤中的表达 - Suppr

Suppr

超能文献

Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms.

作者信息

Mao D, VanVickle S J, Curci J A, Thompson R W

出版信息

Ann Vasc Surg. 1999 Mar;13(2):236-7. doi: 10.1007/s100169900251.

DOI:10.1007/s100169900251

PMID:10072471

Abstract

摘要

相似文献

Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms.基质金属蛋白酶和金属蛋白酶组织抑制因子在人类腹主动脉瘤中的表达

Ann Vasc Surg. 1999 Mar;13(2):236-7. doi: 10.1007/s100169900251.

Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms.基质金属蛋白酶和金属蛋白酶组织抑制因子在人类腹主动脉瘤中的表达。

Ann Vasc Surg. 1998 May;12(3):221-8. doi: 10.1007/s100169900144.

Expression and sequence of the gene for tissue inhibitor of metalloproteinases in patients with abdominal aortic aneurysms.腹主动脉瘤患者金属蛋白酶组织抑制剂基因的表达及序列分析

J Vasc Surg. 1993 Aug;18(2):266-70.

Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms.基质溶解素-1（基质金属蛋白酶-3）和金属蛋白酶组织抑制剂-3在腹主动脉瘤壁中过度表达。

Circulation. 2002 Jan 29;105(4):477-82. doi: 10.1161/hc0402.102621.

Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.腹主动脉瘤壁中基质金属蛋白酶与金属蛋白酶组织抑制剂之间的关系。

Int Angiol. 2003 Sep;22(3):229-38.

Molecular studies of matrix metalloproteinases and tissue inhibitors of metalloproteinases in equine joints.马关节中基质金属蛋白酶和金属蛋白酶组织抑制剂的分子研究

Vet J. 1999 May;157(3):336-8. doi: 10.1053/tvjl.1998.0328.

Expression of collagenase-3 (MMP-13) in human abdominal aortic aneurysms and vascular smooth muscle cells in culture.胶原酶-3（基质金属蛋白酶-13）在人腹主动脉瘤及培养的血管平滑肌细胞中的表达

Biochem Biophys Res Commun. 1999 Aug 11;261(3):904-10. doi: 10.1006/bbrc.1999.1142.

Transcriptional regulation of TIMPs in ascending aorta aneurysms.升主动脉瘤中 TIMPs 的转录调控。

Thromb Res. 2010 Nov;126(5):399-405. doi: 10.1016/j.thromres.2010.08.015. Epub 2010 Sep 21.

Matrix metalloproteinase and tissue inhibitor expression in atherosclerotic and nonatherosclerotic thoracic aortic aneurysms.基质金属蛋白酶和组织抑制剂在动脉粥样硬化性和非动脉粥样硬化性胸主动脉瘤中的表达

J Thorac Cardiovasc Surg. 2007 Jan;133(1):155-61. doi: 10.1016/j.jtcvs.2006.07.036.

Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.涉及细胞外基质重塑和腹主动脉瘤的基因多态性。

J Vasc Surg. 2012 Jan;55(1):171-179.e2. doi: 10.1016/j.jvs.2011.07.051. Epub 2011 Nov 16.

引用本文的文献

Risk Factors and Mouse Models of Abdominal Aortic Aneurysm Rupture.腹主动脉瘤破裂的危险因素和小鼠模型。

Int J Mol Sci. 2020 Sep 30;21(19):7250. doi: 10.3390/ijms21197250.

Tissue-specific relaxin-2 is differentially associated with the presence/size of an arterial aneurysm and the severity of atherosclerotic disease in humans.组织特异性松弛素-2 与人类动脉瘤的存在/大小和动脉粥样硬化疾病的严重程度呈差异相关。

Acta Pharmacol Sin. 2020 Jun;41(6):745-752. doi: 10.1038/s41401-019-0350-5. Epub 2020 Feb 5.

Adult vascular wall resident multipotent vascular stem cells, matrix metalloproteinases, and arterial aneurysms.成人血管壁驻留多能血管干细胞、基质金属蛋白酶与动脉瘤。

Stem Cells Int. 2015;2015:434962. doi: 10.1155/2015/434962. Epub 2015 Mar 18.

Extracellular matrix composition and remodeling in human abdominal aortic aneurysms: a proteomics approach.人腹主动脉瘤细胞外基质组成和重塑：蛋白质组学方法。

Mol Cell Proteomics. 2011 Aug;10(8):M111.008128. doi: 10.1074/mcp.M111.008128. Epub 2011 May 18.

Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm.基质金属蛋白酶抑制剂在预防腹主动脉瘤中的作用。

Ann Vasc Surg. 2007 May;21(3):392-401. doi: 10.1016/j.avsg.2006.11.001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验